493p -14.0 -2.8%
Last Trade - 08/04/20
| Market Cap | £1.40bn |
| Enterprise Value | £1.43bn |
| Revenue | £355.7m |
| Position in Universe | 307th / 1834 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
RWS Holdings plc is a holding company, which provides intellectual property support services (patent translations, international patent filing solutions and searches), in life sciences translations and linguistic validation. The Company provides specialist language service in other technical areas. The Company has four operating segments: RWS Patent Translation & Filing division which provides patent translation and filing services: RWS Patent Information division which provides a range of patent search, retrieval and monitoring services as well as a comprehensive patent database service accessible; RWS Life Sciences division which provides technical translations and linguistic validation to the medical and pharmaceutical sector. This division includes the LUZ, Inc, and RWS Language Solutions division, which provide non-patent or non-life science technical translations.
| Last Annual | September 30th, 2019 |
| Last Interim | September 30th, 2019 |
| Incorporated | December 16, 1994 |
| Public Since | April 19, 2000 |
| No. of Shareholders: | n/a |
| No. of Employees: | 2,523 |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 , |
| Exchange | London Stock Exchange (AIM) |
| Shares in Issue | 275,188,492 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Europa House,Chiltern Park Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom |
| Web | http://www.rws.com |
| Phone | +44 1753 480200 |
| Auditors | PricewaterhouseCoopers LLP |
